208 related articles for article (PubMed ID: 16140296)
1. Plasmodium falciparum: interaction of shikimate analogues with antimalarial drugs.
McRobert L; Jiang S; Stead A; McConkey GA
Exp Parasitol; 2005 Nov; 111(3):178-81. PubMed ID: 16140296
[TBL] [Abstract][Full Text] [Related]
2. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.
Canfield CJ; Pudney M; Gutteridge WE
Exp Parasitol; 1995 May; 80(3):373-81. PubMed ID: 7729473
[TBL] [Abstract][Full Text] [Related]
3. Multiple synergistic interactions between atovaquone and antifolates against Plasmodium falciparum in vitro: a rational basis for combination therapy.
Nduati EW; Kamau EM
Acta Trop; 2006 Mar; 97(3):357-63. PubMed ID: 16457769
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of action of antimalarials. Value of combined atovaquone/proguanil].
Touze JE; Fourcade L; Pradines B; Hovette P; Paule P; Heno P
Med Trop (Mars); 2002; 62(3):219-24. PubMed ID: 12244914
[TBL] [Abstract][Full Text] [Related]
5. Biguanide-atovaquone synergy against Plasmodium falciparum in vitro.
Jones K; Ward SA
Antimicrob Agents Chemother; 2002 Aug; 46(8):2700-3. PubMed ID: 12121961
[TBL] [Abstract][Full Text] [Related]
6. Targeting the shikimate pathway in the malaria parasite Plasmodium falciparum.
McConkey GA
Antimicrob Agents Chemother; 1999 Jan; 43(1):175-7. PubMed ID: 9869588
[TBL] [Abstract][Full Text] [Related]
7. Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.
Edstein MD; Kotecka BM; Anderson KL; Pombo DJ; Kyle DE; Rieckmann KH; Good MF
Antimicrob Agents Chemother; 2005 Oct; 49(10):4421-2. PubMed ID: 16189139
[No Abstract] [Full Text] [Related]
8. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.
Thapar MM; Gil JP; Björkman A
Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):62-70. PubMed ID: 15550263
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium falciparum outwits Malarone, protector of travellers.
Crabb C
Bull World Health Organ; 2003; 81(5):382-3. PubMed ID: 12856058
[No Abstract] [Full Text] [Related]
10. Plasmodium falciparum: the effects of atovaquone resistance on respiration.
Suswam E; Kyle D; Lang-Unnasch N
Exp Parasitol; 2001 Aug; 98(4):180-7. PubMed ID: 11560411
[TBL] [Abstract][Full Text] [Related]
11. [What is the value of the combination atovaquone-proguanil for the clinician?].
Delmont J
Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
[TBL] [Abstract][Full Text] [Related]
12. Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro.
Butcher GA; Sinden RE
Am J Trop Med Hyg; 2003 Jan; 68(1):111-4. PubMed ID: 12556158
[TBL] [Abstract][Full Text] [Related]
13. Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture.
Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI
Ann Trop Med Parasitol; 1997 Jan; 91(1):17-23. PubMed ID: 9093425
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the shikimate pathway in apicomplexan parasites.
Roberts F; Roberts CW; Johnson JJ; Kyle DE; Krell T; Coggins JR; Coombs GH; Milhous WK; Tzipori S; Ferguson DJ; Chakrabarti D; McLeod R
Nature; 1998 Jun; 393(6687):801-5. PubMed ID: 9655396
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility studies of Plasmodium falciparum isolates and clones against cycloguanil and pyrimethamine using the modified in vitro microtechnique.
Ang HH; Chan KL; Mak JW
J Parasitol; 1996 Dec; 82(6):1029-31. PubMed ID: 8973418
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.
Kamchonwongpaisan S; Quarrell R; Charoensetakul N; Ponsinet R; Vilaivan T; Vanichtanankul J; Tarnchompoo B; Sirawaraporn W; Lowe G; Yuthavong Y
J Med Chem; 2004 Jan; 47(3):673-80. PubMed ID: 14736247
[TBL] [Abstract][Full Text] [Related]
17. Direct comparison of antimalarial activity among PS-15 combination therapies by bioassay of serum samples from treated Saimiri sciureus.
Yeo AE
J Parasitol; 1997 Jun; 83(3):515-8. PubMed ID: 9194836
[TBL] [Abstract][Full Text] [Related]
18. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies using the combination atovaquone-proguanil as malaria prophylaxis in non-immune adult and child travelers].
Camus D; Dutoit E; Masson V; Inglebert P; Delhaes L
Med Trop (Mars); 2002; 62(3):225-8. PubMed ID: 12244915
[TBL] [Abstract][Full Text] [Related]
20. Multiple cytochrome B mutations may cause atovaquone resistance.
Meshnick SR; Trumpower B
J Infect Dis; 2005 Mar; 191(5):822; author reply 822-3. PubMed ID: 15688308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
